CG
RAPT

Cutler Group’s RAPT Therapeutics RAPT Stock Holding History

Cutler Group’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$0 Buy
+13
New +$1.81K ﹤0.01% 3331
2021
Q4 		– Sell
-188
Closed -$46K – 5918
2021
Q3 		$46K Sell
188
-1,010
-84% -$267K ﹤0.01% 2579
2021
Q2 		$304K Buy
+1,198
New +$224K 0.01% 1051
2021
Q1 		– Sell
-63
Closed -$10.4K – 6160
2020
Q4 		$9K Buy
+63
New +$13.7K ﹤0.01% 3282

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Cutler Group's RAPT Position: Q1 2024 in Review

Cutler Group opened a new position in RAPT Therapeutics (RAPT) in Q1 2024: 13 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #3331 among its holdings. This is a return to the name: Cutler Group previously reported a position in RAPT as recently as Q3 2021.

Cutler Group first reported a position in RAPT in Q4 2020 and has held it in 4 quarters since. The position peaked at $304K in Q2 2021. 121 funds tracked by Wall St. Rank hold RAPT as of Q1 2024.

  • Cutler Group held 13 shares of RAPT Therapeutics worth $0 as of Q1 2024.
  • RAPT Therapeutics was a new Cutler Group position in Q1 2024.
  • RAPT Therapeutics made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #3331 holding.
  • Cutler Group first reported a position in RAPT Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • Cutler Group's RAPT Therapeutics position peaked at $304K in Q2 2021.
  • 121 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.